RMC-6272

Name: RMC-6272
Brand: TargetMol
SKU: T39959
Rating: 4.5 (1 reviews)

😃Good

Catalog No. T39959Cas No. 2382769-46-0

Alias RMC-6272, RM-006

RMC-6272 (RM-006) is a bi-steric inhibitor that selectively targets mTORC1 with potent inhibition (>10-fold) over mTORC2. Compared to Rapamycin, RMC-6272 shows enhanced inhibition of mTORC1 and induces increased cell death in TSC2 null tumors.

RMC-6272

😃Good

Catalog No. T39959Alias RMC-6272, RM-006Cas No. 2382769-46-0

Pack Size	Price	USA Warehouse	Global Warehouse	Quantity
25 mg	$3,668	Inquiry	Inquiry

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Resource Download

Product Introduction

Bioactivity

Description	RMC-6272 (RM-006) is a bi-steric inhibitor that selectively targets mTORC1 with potent inhibition (>10-fold) over mTORC2. Compared to Rapamycin, RMC-6272 shows enhanced inhibition of mTORC1 and induces increased cell death in TSC2 null tumors.
In vitro	RMC-6272 shows more effective growth inhibition in multiple TSC1 or TSC2 mutant tumor cell lines compared to Rapamycin. RMC-6272 causes a more profound growth inhibition in the TSC1 or TSC2 mutant cells than the wild type cells. RMC-6272 at ~1 nM shows near complete inhibition of p4E-BP1 T37/46 , while inhibition of pS6 S240/244 levels is similar for Rapamycin and RM compounds[1].
In vivo	RMC-6272 significantly decreases the kidney tumor burden in Tsc2 +/- A/J mice within four weeks of treatment. When assessed two months post-treatment cessation, the tumor burden remains notably lower in the RMC-6272 group compared to both the Rapamycin and MLN0128 groups[1].
Synonyms	RMC-6272, RM-006

Chemical Properties

Molecular Weight	1850.25
Formula	C₉₅H₁₄₁FN₆O₂₇S
Cas No.	2382769-46-0
Smiles	[H][C@@]12CC[C@@H](C)[C@@](O)(O1)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@]([H])(C[C@@H](O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C2)OC)[C@H](C)C[C@@H]1CC[C@@H](OC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCS(=O)(=O)c2ccc(C(=O)N3CCOc4ccc(cc4C3)-c3ccc(N)nc3)c(C)c2F)[C@@H](C1)OC
Relative Density.	1.28 g/cm3 (Predicted)

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc